Moorkens, E.; Barcina Lacosta, T.; Vulto, A.G.; Schulz, M.; Gradl, G.; Enners, S.; Selke, G.; Huys, I.; Simoens, S.
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany. Pharmaceuticals 2020, 13, 324.
https://doi.org/10.3390/ph13100324
AMA Style
Moorkens E, Barcina Lacosta T, Vulto AG, Schulz M, Gradl G, Enners S, Selke G, Huys I, Simoens S.
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany. Pharmaceuticals. 2020; 13(10):324.
https://doi.org/10.3390/ph13100324
Chicago/Turabian Style
Moorkens, Evelien, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, and Steven Simoens.
2020. "Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany" Pharmaceuticals 13, no. 10: 324.
https://doi.org/10.3390/ph13100324
APA Style
Moorkens, E., Barcina Lacosta, T., Vulto, A. G., Schulz, M., Gradl, G., Enners, S., Selke, G., Huys, I., & Simoens, S.
(2020). Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany. Pharmaceuticals, 13(10), 324.
https://doi.org/10.3390/ph13100324